UK markets closed
NIKKEI 225
38,356.06 +176.60 (+0.46%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
77.82 -1.30 (-1.64%) GOLD FUTURES
2,354.50 +11.50 (+0.49%) DOW
39,431.67 +0.16 (+0.00%) Bitcoin GBP
48,872.98 -1,363.77 (-2.71%)
PFE Mar 2025 25.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:57PM EDT. Market open.
| Previous close | 4.7000 |
| Open | 4.5500 |
| Bid | 4.1000 |
| Ask | 4.6500 |
| Strike | 25.00 |
| Expiry date | 2025-03-21 |
| Day's range | 4.5500 - 4.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.02k |
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Investor's Business DailyPfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Pfizer stock is now above its key moving averages after reporting better-than-expected first-quarter sales. Is PFE stock a buy now?
BenzingaPfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand “Pfizer for All.” The move, reflected in a recent trademark application, aims to provide medical information, mail-order pharmacy, and telehealth services to US patients. Recent reports indicate Pfizer’s intention to include various medications, including its COVID antiviral Paxlovid and diagnostic kits, on the platform later this year, e
© 2024 Yahoo. All rights reserved.